We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+14.54%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$30.8B
AUM Growth
+$518M
(+1.7%)
Cap. Flow
-$2.73B
Cap. Flow
% of AUM
-8.84%
Top 10 Holdings %
Top 10 Hldgs %
39.95%
Holding
1,143
New
66
Increased
528
Reduced
508
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$176M |
| 2 |
Credo Technology Group
CRDO
|
+$154M |
| 3 |
MACOM Technology Solutions
MTSI
|
+$71.5M |
| 4 |
Rambus
RMBS
|
+$69.5M |
| 5 |
NVMI
Nova
NVMI
|
+$68.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$386M |
| 2 |
NVIDIA
NVDA
|
+$300M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$272M |
| 4 |
Broadcom
AVGO
|
+$248M |
| 5 |
Qualcomm
QCOM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.44% |
| 2 | Financials | 9.98% |
| 3 | Consumer Discretionary | 8.65% |
| 4 | Healthcare | 3.7% |
| 5 | Industrials | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Denali Therapeutics
DNLI
$3.65B
| $2.66M | 0.01% |
182,886
+60,624
| +50% | +$871K |
|
577
Kenvue
KVUE
$36.9B
| $2.65M | 0.01% |
163,550
+857
| +0.5% | +$17.5K |
|
578
Labcorp
LH
$25B
| $2.65M | 0.01% |
9,226
+383
| +4% | +$103K |
|
579
CVB Financial
CVBF
$3.94B
| $2.64M | 0.01% |
139,761
+26,415
| +23% | +$526K |
|
580
Cloudflare
NET
$99B
| $2.64M | 0.01% |
12,313
-3,853
| -24% | -$787K |
|
581
Expedia Group
EXPE
$35.4B
| $2.64M | 0.01% |
12,344
-1,037
| -8% | -$208K |
|
582
Apogee Therapeutics
APGE
$10.1B
| $2.61M | 0.01% |
65,796
+23,585
| +56% | +$901K |
|
583
Emcor
EME
$35.2B
| $2.61M | 0.01% |
4,022
+3,240
| +414% | +$1.97M |
|
584
International Bancshares
IBOC
$4.76B
| $2.61M | 0.01% |
37,925
-5,362
| -12% | -$375K |
|
585
AeroVironment
AVAV
$7.56B
| $2.6M | 0.01% |
8,267
+965
| +13% | +$250K |
|
586
Ulta Beauty
ULTA
$22B
| $2.56M | 0.01% |
4,676
-91
| -2% | -$46.6K |
|
|
GRAL
587
GRAIL Inc
GRAL
$2.94B
| $2.54M | 0.01% |
43,009
+1,977
| +5% | +$75.5K |
|
588
Vera Therapeutics
VERA
$2.3B
| $2.54M | 0.01% |
87,497
+15,429
| +21% | +$357K |
|
589
IDEAYA Biosciences
IDYA
$3.42B
| $2.53M | 0.01% |
93,152
-16,655
| -15% | -$403K |
|
590
Pathward Financial
CASH
$1.86B
| $2.53M | 0.01% |
34,148
+1,943
| +6% | +$151K |
|
591
Celldex Therapeutics
CLDX
$2.99B
| $2.52M | 0.01% |
97,460
+25,902
| +36% | +$600K |
|
592
Broadridge
BR
$17.8B
| $2.51M | 0.01% |
10,545
-62
| -0.6% | -$15.4K |
|
593
FirstEnergy
FE
$28B
| $2.51M | 0.01% |
54,713
-483
| -0.9% | -$20.6K |
|
594
WaFd
WAFD
$2.72B
| $2.49M | 0.01% |
82,202
-4,507
| -5% | -$138K |
|
595
CG Oncology
CGON
$6.28B
| $2.48M | 0.01% |
61,684
-18,544
| -23% | -$539K |
|
596
Century Communities
CCS
$1.91B
| $2.47M | 0.01% |
38,972
+17,157
| +79% | +$1.08M |
|
597
BancFirst
BANF
$3.79B
| $2.47M | 0.01% |
19,496
+5,116
| +36% | +$661K |
|
598
Disc Medicine
IRON
$2.96B
| $2.46M | 0.01% |
37,302
+5,813
| +18% | +$346K |
|
599
Williams-Sonoma
WSM
$26.9B
| $2.46M | 0.01% |
12,602
-464
| -4% | -$88.7K |
|
600
Biohaven
BHVN
$2.03B
| $2.46M | 0.01% |
163,569
+42,380
| +35% | +$617K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Rafferty Asset Management held 1,143 positions worth $30.8B, up 1.7% from $30.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rafferty Asset Management withdrew a net $2.73B in Q3 2025, closing 39 positions and reducing 508 holdings. Its most notable exit was Qorvo, an estimated $103M position sold in full.
By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in Astera Labs worth $210M.
- Rafferty Asset Management's largest Q3 2025 buy was Astera Labs: 1,070,475 shares worth $210M.
- Rafferty Asset Management added most to Invesco QQQ Trust in Q3 2025, an estimated $42.9M increase.
- Rafferty Asset Management's biggest Q3 2025 reduction was Advanced Micro Devices, cutting an estimated $386M.
- Rafferty Asset Management fully exited Qorvo in Q3 2025, selling an estimated $103M.
- Rafferty Asset Management's ten largest holdings make up 40% of its $30.8B portfolio in Q3 2025.
- Rafferty Asset Management opened 66 new positions and closed 39 in Q3 2025.
- Rafferty Asset Management's portfolio value rose 1.7% quarter-over-quarter to $30.8B.
Based on Rafferty Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.